Evaluating a Telemedicine Program Using the ESTOI Mobile App for Adults with Asthma A 52-Week Randomized Study at Bellvitge University Hospital

What this Trial Is About

Asthma is a common and chronic lung condition that can be challenging to control in severe cases. This research aims to evaluate the effect of using a mobile application called ESTOI on asthma control, treatment adherence, and quality of life over a 52-week period. The study involves adults diagnosed with asthma and is conducted at a specialized hospital in Spain, focusing on improving disease management through digital support. Participants will be randomly assigned to one of two groups. The intervention group will receive standard care plus access to the ESTOI app, which offers symptom tracking, personalized treatment information, peak flow recording, nutritional guidance, and messaging with healthcare providers. The control group will receive usual care and asthma education without app access. Both groups will use a Peak Flow Meter and follow a schedule of three visits across the year. During the study visits, participants will complete questionnaires assessing asthma control, inhaler use, quality of life, and anxiety or depression. They will undergo lung function tests, blood tests, and exhaled nitric oxide measurements. Data on medication use and asthma exacerbations will be collected and monitored. The study will analyze these outcomes to understand how the app influences asthma management and patient wellbeing over one year.

Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma